PARP inhibitor maintenance for primary ovarian cancer - A missed opportunity for precision medicine. Wethington SL, Wahner-Hendrickson AE, Swisher EM, Kaufmann SH, et al. Gynecol Oncol 2021 Aug 11. pii: S0090-8258(21)00647.

Read + Share

Amedeo Smart

Independent Medical Education

Wethington SL, Wahner-Hendrickson AE, Swisher EM, Kaufmann SH, et al. PARP inhibitor maintenance for primary ovarian cancer - A missed opportunity for precision medicine. Gynecol Oncol 2021 Aug 11. pii: S0090-8258(21)00647.
PMID: 34391577